@article{JTD13197,
author = {Jian-Cang Zhou and Nan Zhang and Zhong-Heng Zhang and Ting-Ting Wang and Yue-Feng Zhu and Hui Kang and Wei-Min Zhang and Dong-Lin Li and Wei-Dong Li and Zhen-Jie Liu and Xi-Min Qian and Ming-You Zhang and Jue Wang and Mi Zhou and Zhi-Tao Yang and Yun-Xian Yu and Hang-Yang Li and Jian Zhang and Yong-Gang Wang and Jian-Ping Gao and Lin Ling and Kong-Han Pan and for the Pressure in Acute Type B Aortic Dissection (RAID) study group},
title = {Intensive blood pressure control in patients with acute type B aortic dissection (RAID): study protocol for randomized controlled trial},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {5},
year = {2017},
keywords = {},
abstract = {Background: Blood pressure control is an essential therapy for patients with acute type B aortic dissection (ABAD) and should be maintained throughout the entire treatment. Thus, vast majority current guidelines recommend control the blood pressure to lower than 140/90 mmHg. Theoretically, a much lower target may further decrease the risk of propagation of dissection. However, some argued that too lower blood pressure would compromise the organ perfusion. Thus, there is no unanimous optimal target for blood pressure in patients with ABAD so far. The present study aimed to investigate the optimal blood pressure target for patients with ABAD, in the hope that the result would optimize the treatment of aortic
dissection (AD).
Methods: The study is a multi-center randomized controlled clinical trial. Study population will include patients with new diagnosed ABAD and hypertension. Blocked randomization was performed where intensive blood pressure control (},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/13197}
}